Page last updated: 2024-09-05

alagebrium and Obesity

alagebrium has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kersten, JR; LaDisa, JF; Passerini, AG; Rajamani, A; Schrepfer, S; Toth, JM; Wang, H; Weihrauch, D1
Andrikopoulos, S; Bierhaus, A; Chand, V; Cooper, ME; Coughlan, MT; de Courten, B; de Courten, MP; Dougherty, SL; Forbes, JM; Harcourt, BE; Kingwell, BA; Morley, AL; Penfold, SA; Sourris, KC; Thallas-Bonke, V; Thomas, MC; Walker, KZ1

Trials

1 trial(s) available for alagebrium and Obesity

ArticleYear
Targeted reduction of advanced glycation improves renal function in obesity.
    Kidney international, 2011, Volume: 80, Issue:2

    Topics: Adolescent; Adult; Animals; Cross-Over Studies; Diet; Glycation End Products, Advanced; Humans; Inflammation; Kidney; Kidney Diseases; Male; Mice; Mice, Knockout; Middle Aged; Obesity; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles; Young Adult

2011

Other Studies

1 other study(ies) available for alagebrium and Obesity

ArticleYear
Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats.
    American journal of physiology. Heart and circulatory physiology, 2015, Volume: 309, Issue:7

    Topics: Animals; Aorta, Abdominal; Collagen; Diabetes Mellitus; Glycation End Products, Advanced; Graft Occlusion, Vascular; Male; Neointima; Obesity; Rats; Rats, Zucker; Receptor for Advanced Glycation End Products; Shear Strength; Stents; Stress, Mechanical; Thiazoles; Transforming Growth Factor beta; Vascular Resistance

2015